Atlas Trials

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

Clinical trial NCT03254654 · COMPLETED

Trial details

NCT number
NCT03254654
Sponsor
Fudan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Triple-Negative Breast Cancer
Start date
2017-08-16
Primary completion
2021-08-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.